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Abstract
Conditional gene targeting strategies are progressively used to study gene function tissue-specifically and/or at a defined
time period. Instrumental to all of these strategies is the generation of targeting vectors, and any methodology that would
streamline the procedure would be highly beneficial. We describe a comprehensive transposition-based strategy to produce
gene-targeting vectors for the generation of mouse conditional alleles. The system employs a universal cloning vector and
two custom-designed mini-Mu transposons. It produces targeting constructions directly from BAC clones, and the alleles
generated are modifiable by Cre and Flp recombinases. We demonstrate the applicability of the methodology by modifying
two mouse genes, Chd22 and Drapc1. This straightforward strategy should be readily suitable for high-throughput targeting
vector production.
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Introduction
In mouse, conditional gene knockout (cko) strategies have
provided means to study the effects of gene inactivation in a tissue-
specific manner and/or at a defined time period [1]. The most
widely applied strategies for conditional mutagenesis take
advantage of site-specific recombinases; particularly the Cre/loxP
system of bacteriophage P1 [2] has been used extensively for the
purpose [3].
Engineering the targeting vector construction is arguably one of
the most time-consuming steps in cko strategies. Conventional
methods for the construction of cko vectors include finding
appropriate restriction enzyme cleavage sites in the genome, and
several cloning steps to insert loxP sites as well as positive and
negative selection markers into the construction. To complement
the conventional methods, alternative strategies have recently been
developed to construct cko targeting vectors. These strategies
employ PCR in combination with homologous recombination
(recombineering) [4–6], or they are based on the utilization of in
vitro reactions of several DNA transposition systems, such as Ty1
[7], phage Mu [8–10], or Tn5/Tn7 [11]. Although the currently
available cko vector construction strategies are adequate for many
transgenic projects, a general strategy that would further
streamline the vector engineering procedure would be highly
beneficial. In addition, the strategy should preferentially incorpo-
rate two commonly used site-specific recombination systems, Cre/
loxP [2] and Flp/FRT [12], to allow versatile possibilities for the
removal of selection cassettes in mouse ES cells or animals [3].
Mu DNA transposition reaction is one of the best-characterized
transposition reactions [13], and a minimal version of it can be
reproduced in in vitro conditions using MuA transposase,
transposon DNA, and target DNA as the only macromolecular
components [14]. Importantly, the relatively random transposon
insertion spectrum allows near-saturating mutagenesis whereby
insertions can be targeted to almost every residue in the target
sequence [15]. The minimal in vitro reaction has recently been used
in a variety of molecular biology, protein engineering, and
genomics applications [16–24]. We have shown earlier that Mu
in vitro transposition can be used to produce several types of mouse
gene targeting constructions, including those generating null,
hypomorphic, or conditional alleles [8]. This proof of principle
study, employing mouse DNA subcloned in a plasmid vector,
established the basic methodology and prompted us to examine
possibilities for ever more advanced utilization of the technology.
Here, we describe a highly efficient Mu in vitro transposition-
based approach to generate cko targeting vectors directly from
BAC clones. By targeting the mouse Cdh22 [25] and Drapc1 [26]
loci, we show that the strategy provides a straightforward means to
produce conditional alleles.
Results
MuA transposase catalyzes transposon integration into any
DNA in an in vitro reaction and produces essentially random
distribution of transposon insertions along the target sequence
[14]. We describe a strategy for the generation of cko targeting
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4341plasmids by employing two successive Mu transposition reactions
to introduce a loxP site on one side of the exon of interest and a
marker gene flanked by loxP sites and FRT sites on the other side
of that exon. Initially, we constructed a universal cloning vector
(pHTH22) suitable for essentially any cko project in mouse
(Figure 1A). For negative selection in mouse ES cells [27], it
contains the HSV TK gene flanked by the mouse PGK promoter
and terminator. For cloning and linearization, it contains an array
of unique restriction sites (Figure 1B), including several 8-cutter
sites, and a homing endonuclease site (PI-SceI). We also
constructed two selectable marker-containing mini-Mu transpo-
sons (Figure 1C). The first transposon, Kan/Neo-loxP-Mu,
contains a bacterial promoter, the SV40 early promoter, the
Kan/Neo resistance-encoding gene from Tn5, and the polyade-
nylation signal from HSV TK gene. This resistance cassette is
flanked by two loxP direct repeats and embedded between two 50-
bp inverted repeat Mu R-end sequences. The second transposon,
Kan/Neo-loxP-FRT-Mu, contains two additional FRT sites as
direct repeats. The functionality of the transposons, particularly
Mu R-ends, was confirmed by in vitro transposition into an external
target plasmid (data not shown). The functionality of the Cre/loxP
and Flp/FRT recombination systems was tested by introducing
appropriate transposon-containing plasmids into E. coli strains
expressing Cre or Flp recombinase. As a result, all expected
deletion derivatives of plasmids were formed, verifying the
functionality of the two recombination systems (data not shown).
Targeting vector for mouse Cdh22 gene
We applied the devised strategy (Figures 2) to generate a
conditional Cdh22 gene (MGI:1341843) knockout allele. As the
initial transposition reaction target DNA, we used a KpnI digest
of the identified BAC clone (110 kb), which contained the exon 3
of the mouse Cdh22 gene in a 9 kb fragment. As the donor DNA,
we used Kan/Neo-loxP-Mu transposon, containing the selectable
Kan/Neo gene cassette between two loxP sites. Using selection
for ampicillin and kanamycin resistance, transposition reaction
products were cloned into the targeting vector as a pool,
generating a plasmid library of ,3,100 Amp
R/Kan
R clones.
We pooled 300 transformant clones in six pools, each containing
50 colonies, isolated plasmid DNA from these pooled samples,
and screened the DNA by PCR for suitably located transposon
insertions (Figure 3A). Three of these pools produced a
prominent PCR product, the length of which fell within the
desired size range (100–1,000 bp). Original clones from these
three pools were then analyzed individually by colony PCR.
Three clones, one from each pool, generated a PCR product that
matched in size those products observed with pooled samples,
indicating the presence of the transposon in the vicinity of the
exon 3 in these three clones.
Most of the transposon DNA was then eliminated from these
three integrant clones by introducing the plasmids into the E. coli
strain expressing Cre recombinase. Site-specific recombination in
vivo removed the selection cassette, leaving behind the Mu R-ends
and one loxP site; and this was confirmed by sequencing.
Sequencing also identified the exact location of the insertion in
the selected three plasmid clones: 211, 368, and 462 bp upstream
from the exon 3.
Next, the second transposon, Kan/Neo-loxP-FRT-Mu, with
two additional FRT sites (‘‘floxed’’ and ‘‘flrted’’ Kan/Neo gene
cassette) was integrated in vitro into the construct that contained
remnants of the first transposon 368 bp from the exon 3. In this
case, we first assembled DNA transposition complexes by
incubating the transposon with MuA transposase and then
included the target DNA, followed by the addition of Mg
2+ ions.
The assembly of Mu transposition complexes is a slow process
when compared to target capture and strand transfer steps of
transposition. Thus, the use of pre-assembled complexes with a
short incubation time thereafter prevents the target DNA from
acting as a transposon, a formal possibility, as the target plasmid
contains two Mu R-ends left over from the first integrated
transposon. Transposition reaction products were then electropo-
rated into E. coli DH10B cells, and proper clones were selected on
plates containing ampicillin and kanamycin. We screened 80
transformants by colony PCR (Figure 3A), and six of the clones
apparently contained a suitably located transposon, as indicated by
a PCR product of appropriate size. One clone was selected, and
subsequent sequence analysis confirmed a correct orientation and
location of the second transposon 1,618 bp downstream from the
exon 3.
Targeting vector for mouse Drapc1 gene
As another example, we generated a conditional knockout allele
for Drapc1 gene (MGI:3513977). In the initial transposition
reaction, we used an NsiI restriction digest of the BAC clone
containing exons 2 and 3 as the target DNA, and Kan/Neo-loxP-
Mu transposon as the donor. The desired NsiI fragment was
15.1 kb in length, containing the exons 2 and 3 with an
intervening 2.8 kb intron and 5.2 kb upstream and 6.6 kb
downstream regions. The reaction products were cloned into the
targeting vector as a pool, generating a plasmid library of ,6,700
Amp
R/Kan
R transformants. The library was divided into forty
pools (,170 colonies per pool), and these pools were screened by
PCR (Figure 3B). In this case, two of the pools generated a PCR
product of appropriate size. Next, individual clones from one of
the identified pools were analyzed by colony PCR for the
respective transposon integration. A proper candidate clone was
found; sequencing verified the transposon orientation and
confirmed its location 1,220 bp upstream from the exon 2. Most
of the transposon was again removed in the Cre-expressing E. coli
strain. Next, the other transposon, Kan/Neo-loxP-FRT-Mu, was
introduced by in vitro transposition as described for Cdh22. A total
of 150 transformants were analyzed for PCR products as pools
(Figure 3B), each pool containing ten transformants, and one of
the pools generated a PCR product of appropriate size. The
colonies from this pool were then analyzed individually by colony
PCR, and a colony was identified that evidently was responsible
for the abovementioned PCR product. Sequencing of this clone
confirmed the correct orientation of the transposon and identified
its exact location 964 bp downstream from exon 3.
Functionality of the loxP and FRT sites
To verify experimentally the orientation and functionality of the
loxP and FRT sites, the targeting constructs for Cdh22 and Drapc1
were introduced into E. coli strains 294-Cre and 294-Flp. These
strains thermoinducibly express Cre and Flp recombinases,
respectively, and can be used to monitor recombination-
proficiency of plasmids [28]. In all four cases, site-specific
recombination proceeded as expected (Figure 4), verifying
authenticity of the constructions.
Gene targeting in mouse ES cells
The final constructions for Cdh22 and Drapc1 were linearized
with NotI and SacII, respectively, and subsequently electrotrans-
fected into mouse ES cells, selecting for the marker residing within
the transposon (G418) and for the loss of the TK marker
(ganciclovir). The selected ES clones were screened by Southern
analysis with appropriate 59 and 39 probes to verify correct
targeting. Six correctly targeted clones were identified for Cdh22
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of 5.4 and 5.7%, respectively. Figures 5 and 6 show the restriction
maps and Southern analyses of the wt as well as mutated Cdh22
cond
and Drapc1
cond alleles. The correctly targeted ES cell clones were
used to generate mouse chimeras, which transmitted the targeted
Cdh22
cond and Drapc1
cond alleles through the germ-line (Figures 7
Figure 2. Flowchart for the construction of conditional knockout vectors. Part A. (i) an entire BAC clone is initially digested with an
appropriate restriction endonuclease, and (ii) the ensuing fragment pool is then used as a target for the first transposition reaction. (iii) The fragment
pool is subsequently ligated into a suitable vector plasmid, and those clones that include transposon-containing BAC fragments are selected using
both the transposon marker and vector marker. Next, (iv) a plasmid clone that contains a transposon insertion in a desired location is identified by a
PCR screen with appropriate primers, one transposon specific and the other target specific. (v) The chosen plasmid is then introduced into an E. coli
strain that expresses Cre recombinase. The selectable marker is eliminated by Cre recombination in vivo, leaving a single loxP site in the construction.
Part B. The second transposition reaction (vi) using pre-assembled transposition complexes (vii) introduces into the construction a marker gene
that is flanked by loxP and FRT sites. (viii) As above, a suitable clone is screened by PCR to identify a plasmid, which contains the second transposon
inserted in a suitable location and orientation on the opposite side (to the first transposon) of the exon of interest. Genomic DNA is shown with a
black line, and the orange rectangle denotes an exon. The transposons are shown with black bars featuring the Kan/Neo cassette (green arrow), loxP
sites (white triangles), FRT sites (white pentagons), and transposon ends (black rectangles).
doi:10.1371/journal.pone.0004341.g002
Figure 1. Details of the genetic tools used. (A) Structure and characteristic elements of the multicopy cloning vector pHTH22 with unique
restriction sites indicated. The gene region encoding HSV thymidine kinase (TK) under the control of mouse phosphoglycerate kinase promoter and
terminator is shown with a black curved arrow. The vector portion of the plasmid including the gene for ampicillin resistance (Amp
R) and pUC19
origin of replication (ori) are shown with gray symbols (curved arrow and rectangle). (B) The nucleotide sequence of the polylinker and its flanking
regions in pHTH22. The polylinker is shown in boldface with enzyme recognition sites underlined. The arrows indicate the binding sites of primers
that were used for the confirmatory sequencing of genomic inserts’ ends. (C) Structures of the Kan/Neo-loxP-Mu and Kan/Neo-loxP-FRT-Mu
transposons. The transposons contain bacterial (pbact) and eukaryotic (pSV40) promoters (short arrows), a marker gene (Kan/Neo) conferring resistance
to kanamycin in bacteria and G418 in eukaryotes (black arrow), and the HSV thymidine kinase polyadenylation (HSV TK polyA) signal (small rectangle).
The loxP sites are indicated by triangles and FRT sites by pentagons. The rectangles in the transposon ends indicate 50 bp of Mu R-end DNA
sequences in inverted orientation relative to each other. For the sake of clarity, the features are not in scale. The BglII sites in the ends are used to
excise the transposons from their carrier plasmids. The sequences of the transposon-containing plasmids pHTH19 (Kan/Neo-loxP-Mu) and pHTH24
(Kan/Neo-loxP-FRT-Mu) are available upon request.
doi:10.1371/journal.pone.0004341.g001
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generate a null allele of Cdh22, mice carrying the Cdh22
cond allele
were crossed with mice carrying PGK-Cre transgene. In the double
heterozygous (Cdh22
cond/+; PGK-Cre/+) offspring, the Cdh22
cond
allele was efficiently converted by Cre-mediated recombination to
Cdh22
del allele, where the sequence between the LoxP sites was
deleted (Figure 7). Similarly, also Drapc1
del allele was produced
(Figure 8).
Discussion
We present a new strategy to produce gene targeting vectors for
the generation of conditional knockout mutations in the mouse.
To validate the methodology, we used the strategy to construct
targeting vectors for Cdh22 and Drapc1 genes. These vectors were
used for gene targeting in mouse ES cells, and the resulting
conditional alleles were transmitted through the germ line.
Figure 3. PCR screening of transposon-containing plasmid clones. (A) Cdh22 locus. The first transposon insertion was screened using the
primer pair 1B59/1B39. The second transposon insertion was screened using the primer pair 2B59/HSP430. (B) Drapc1 locus. The first transposon
insertion was screened using the primer pair N2/HSP507. The second transposon insertion was screened using the primer pair HSP430/HSP518. In
both panels, the relevant distances from the identified transposon insertion site to the 59 ends of the primers are shown in base pairs (bp). For the
sake of clarity, figure elements are not drawn in scale.
doi:10.1371/journal.pone.0004341.g003
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characteristics. For the selection against random integration in
mouse ES cells, it contains the HSV TK gene. The array of
multiple restriction endonuclease sites provides versatile possibil-
ities for the choice of the genomic restriction fragments utilized
and for the final linearization procedure prior to the delivery into
ES cells. In addition, a homing endonuclease site is included for
the linearization, and it can be used if none of the restriction
enzyme sites is acceptable for that. The multicopy nature of the
vector ensures a convenient plasmid production.
The strategy also includes two transposons, both of which
contain the antibiotic-resistance cassette (Kan/Neo), selectable
both in bacteria and mammalian cells and removable by Cre
recombination. One of the transposons also contains a pair of
FRT sites, enabling the excision of the resistance cassette by Flp-
mediated recombination. Since the first report of the phage Cre/
loxP system functioning in mammalian cells [29], both the Cre/
loxP system and later the yeast Flp/FRT system have been shown
to be effective in removing selectable markers in several types of
mouse cells, including ES cells [30–33]. As the presence of a
selectable marker within the modified locus can potentially
influence the expression of the targeted gene [34,35], a marker
removal system is essential in any gene targeting strategy. In the
described system, the most straightforward option to remove the
positive selection cassette is the utilization of Flp recombination, as
only two FRT sites are present in the modified locus. Although
Figure 4. Verification of the functionality of the Cre/loxP and Flp/FRT site-specific recombination systems in the context of the gene
targeting constructions. The final constructions were introduced into E. coli strains 294-Cre and 294-Flp, expressing Cre and FLP recombinase,
respectively [28]. From each strain, two independent plasmid isolates, marked C1 and C2 (from the 294-Cre strain) or F1 and F2 (from the 294-Flp
strain), were subjected to restriction analysis (on the left). On these analyses, the original targeting plasmid is marked with T. On the right are shown
the respective plasmid maps with the relevant restriction enzyme as well as LoxP and FRT sites indicated (BamHI, XbaI and HindIII sites are indicated
with B, X and H, respectively). (A) Analysis of the targeting construction for the Cdh22 locus. As the size marker serves the XbaI digestion of the
respective targeting construction. (B) Analysis of the targeting construction for the Drapc1 locus. As the size marker serves the HindIII digestion of the
respective targeting construction.
doi:10.1371/journal.pone.0004341.g004
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presence of three loxP sites necessitates a somewhat more
meticulous screening phase. A marker removal in this system
leaves behind a DNA segment that contains a pair of 50 bp Mu R-
end sequences as an inverted repeat and an intervening sequence
of 67 bp (Kan/Neo-loxP-Mu) or ,120 bp (Kan/Neo-loxP-FRT-
Mu) including the recombination signal(s). As these segments are
relatively short, and they do not contain detectable splicing signals
or polyadenylation sites, their presence in an intron is expected to
have no or negligible effects on the level of gene expression from
the modified loci. However, a degree of caution with this respect is
warranted, as unpredictable locus-specific differences may possibly
exist. We have shown that the marker-removed configurations are
stable in plasmids, as no secondary rearrangements were observed
in those plasmids that were isolated from recombinase-expressing
E. coli strains (Figure 4). We have also shown that Cre-recombined
alleles are stable in the mouse, as clear signals of stable loci were
seen in the Southern analyses of the deletion allele mice (Figures 7
and 8). Given that Flp-recombined configurations are stable in
plasmids (Figure 4), and because the respective alleles in mice
would be very similar to those rearranged by Cre, we believe that
Flp-recombined alleles are stable in mice, although this has not
been verified experimentally.
In general, the use of DNA transposition strategies alleviates the
requirement of finding appropriate restriction sites close to an
exon of interest. In addition, with transposon strategies several
constructions aimed at targeting different exons can be generated
simultaneously. In Mu transposition, the target DNA sites are
selected with a low stringency of sequence specificity [15], yielding
essentially random distribution of integrations along longer regions
of DNA [14,16]. Accordingly, the target site selection of Mu
transposition is optimally suited for the purpose established in this
study.
In contrast to several published transposon protocols [6,10,11],
the manipulation in our strategy is initiated directly from a BAC
clone, and no prior subcloning of a particular restriction fragment
is needed. During the transposon-assisted cloning step, a
convenient double selection for the transposon (Kan
R) and vector
(Amp
R) markers ensures that all cloned fragments surely contain
the transposon. The probability of obtaining plasmid clones with
two or more transposon insertions is very low because, in the
reaction conditions used, most of the target DNA fragments do not
experience even a single transposon integration [14,16]. Never-
theless, because double integrations would be detrimental to the
strategy, appropriate restriction analysis, or preferably sequencing
with transposon-specific outwards-reading primers, should be used
Figure 5. Targeting strategy for the conditional inactivation of the Cdh22 gene. (A) Restriction maps of the mouse wild type Cdh22 locus,
the targeting vector, and the targeted allele. Relevant restriction sites: E, EcoRI; K, KpnI. Vertical dotted lines highlight homologous regions. (B)
Southern analysis of genomic DNA from ES cells (EcoRI digestion), with the 59-probe illustrating the 21.5 kb wild type (wt) and 10.5 kb targeted
(cond) alleles. (C) Southern analysis of genomic DNA from ES cells (EcoRI digestion), with the 39 probe illustrating the 21.5 kb wild type (wt) and
8.9 kb targeted (cond) alleles.
doi:10.1371/journal.pone.0004341.g005
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study, sequencing also indicates the exact site of the transposon
integration.
Following the initial transposon-assisted cloning step, the most
convenient means to identify transposon-containing recombinant
clones for further manipulation is arguably the use of PCR-based
screening with sample pooling [36,37]. Even in cases where the
exon of interest resides in a sizeable restriction fragment, a suitable
clone can be identified with a reasonable effort. In this study the
targeted exon of the Cdh22 gene was in a 9 kb KpnI fragment, a
medium size fragment among those produced by the respective
BAC clone. In this case, the screening of 300 colonies identified
three suitable clones for further manipulation. In the Drapc1 BAC
clone, the two exons of interest were resident in a 15.1 kb NsiI
fragment, which is one of the largest NsiI fragments of this BAC,
generating a more challenging test case for the utility of the
strategy. Even with this large fragment, two potentially suitable
integrant clones were identified among 6,700 colonies with relative
ease by the use of 40 pooled samples in the initial screening phase.
Thus, it is straightforward to obtain desired transposon-containing
recombinant plasmids with genomic inserts of 10–15 kb, a size
range typically used for standard gene targeting projects. As a last
step during the screening phase, we successfully used colony PCR,
and this method proved to be highly effective and fast in
identifying the final targeting constructions. The size range of
PCR products that would identify a suitably located transposon is
critically dependent on the resolution of the gel used and the
performance of the DNA polymerase applied. In our study, PCR
products ranging in size from 285 bp to 1,934 bp identified
suitably located transposons (Figure 3).
Our strategy complements other targeting vector construction
methods and offers certain key advantages: (1) The cloning vector
and two transposons are generally usable and can be applied to
modify any mouse gene. (2) No prior subcloning of BAC clone
fragments or PCR amplification of marker cassettes flanked by
homology regions is needed. (3) The first transposon can be
integrated in one reaction into different locations over the entire
length of the BAC clone, yielding a variety of possibilities for the
choice of the targeted exon. (4) Both positive and negative
selection markers are included. (5) Only one protein, MuA
transposase, is needed. (6) Both loxP and FRT sites are present in
the final gene targeting construct, allowing versatile possibilities for
the gene modification in a variety of tissues and/or during
different developmental stages.
Figure 6. Targeting strategy for the conditional inactivation of the Drapc1 gene. (A) Restriction map of the mouse Drapc1 locus, the
targeting vector and the targeted allele. Relevant restriction sites: A, AvrII; B, BamHI; N, NsiI. Vertical dotted lines highlight homologous regions. (B)
Southern analysis of genomic DNA from ES cells (BamHI digestion), with the 59 probe illustrating the 6.4 kb wild-type (wt) and 4.9 kb targeted (cond)
alleles. (C) Southern analysis of genomic DNA from ES cells (AvrII digestion), with the 39 probe illustrating the 14.2 kb wild type (wt) and 6.4 kb
targeted (cond) alleles.
doi:10.1371/journal.pone.0004341.g006
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gene-targeting vector construction. Zhang et al. [10] used mini-Mu
transposons, and Aoyama et al. [11] used a combination of two
transposons, Tn5 and Tn7. Many features in these two strategies
do share similarities with our strategy. However, important
differences also exist. For example, in the abovementioned two
strategies, the modified gene region is initially subcloned into a
plasmid vector. Negative selection was not employed in the Mu
methodology, and two different transposon systems were used in
the Tn5/Tn7 methodology.
One of the advantages in our strategy, avoiding laborious initial
cloning steps in gene-targeting vector construction, has been
achieved also with recombineering, i.e. the use of homologous
recombination in E. coli [5]. This method has been used to
introduce loxP and FRT sites, and selection markers into genomic
DNA [6]. Compared to transposon strategies, because of the PCR
amplification step to insert homology regions, recombineering
requires relatively long specific primers for each individual
targeting construct. However, the advantage is that each particular
locus can be modified very accurately as desired.
We have developed a fast and efficient Mu in vitro transposition-
based procedure to construct targeting vectors directly from BAC
clones without the need for prior subcloning. A general-purpose
cloning vector and two custom-designed transposons provide a
tool set for any conditional knockout project in mouse. The data
indicate that the strategy described here is an easy, efficient, and
versatile method for generating conditional knockout alleles.
Furthermore, the procedure should be readily suitable for high-
throughput targeting vector production.
Materials and Methods
Ethics statement
All the experiments involving animals were approved by the
committee of experimental animal research of the University of
Helsinki.
DNA techniques. Standard enzymes for DNA work [38]
were from New England Biolabs. DyNAzyme II DNA polymerase
(for cloning), Phusion DNA polymerase (for colony PCR), and
MuA transposase were from Finnzymes. Enzymes were used as
recommended by the suppliers. The BACs used were screened
from the 129S6/SvEvTac mouse BAC library RPCI-22
(BACPAC Resources). Qiagen kits were used for DNA isolation.
Standard DNA techniques were performed as described [38]. The
colony PCR method was modified from a previously published
protocol [39]. Briefly, a single colony was picked from a selection
plate and suspended in 50 ml of water. One microliter of this
suspension was then used as a template in PCR amplification,
Figure 7. Comparison of wild type, conditional, and deletion alleles of the mouse Cdh22 locus. (A) A schematic of wild-type (wt),
conditional (cond), and Cre-recombined (del) Cdh22 alleles. (B) Southern blot analysis of DNA isolated from the tails of mice carrying different Cdh22
alleles (EcoRV digestion), with the 39probe illustrating the 14.6 kb wild type (wt), 17.0 kb conditional (cond), and 12.6 kb deletion (del) alleles.
doi:10.1371/journal.pone.0004341.g007
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recommendations of the supplier. Each PCR amplification
included one transposon-specific and one locus-specific primer
(Figure 3).
Cloning vector. The herpes simplex virus (HSV) thymidine
kinase (TK) gene cassette including the mouse phosphoglycerate
kinase (PGK) promoter and terminator was cloned from plasmid
pPNTloxP [40], as an EcoRI-HindIII fragment, into plasmid
pUC19 (New England Biolabs) that had been cleaved with the
same two enzymes, yielding pHTH21. A polylinker was then
generated by annealing and ligating oligonucleotides HSP478
through HSP484 (Table 1). The polylinker was PCR-amplified
using primers HSP485 and HSP486; and cloned, as an EcoRI
fragment, into the EcoRI site of pHTH21. Finally, one of the
EcoRI sites was eliminated by partial digestion, end-filling with
Klenow enzyme, and ligation to generate plasmid pHTH22
(Figure 1A and 1B).
Transposons. Two related mini-Mu transposons (Figure 1C)
were constructed using standard PCR and cloning procedures.
Similar to the transposons in earlier studies [14,20], these
transposons were produced as a segment of their pUC19-derived
carrier plasmids. Plasmids pHTH19 and pHTH24 carry Kan/
Neo-loxP-Mu and Kan/Neo-loxP-FRT-Mu transposons,
respectively. Both of these transposons contain the selection
cassette from plasmid pIRES2-EGFP (Clontech), including two
promoters, prokaryotic (pbact) and eukaryotic (pSV40), in addition
to the Kan/Neo resistance-encoding gene from Tn5 and
polyadenylation signals from the HSV TK gene. The Kan/Neo
marker gene can be used both with E. coli (kanamycin selection)
and mammalian cells (G418 selection). Flanking the selection
cassette, the transposons contain a transposon-specific set of Cre
and Flp recombination sites, and the extreme transposon termini
each include 50 bp from Mu R-end as an inverted repeat to
provide critical MuA transposase binding sites. The transposons
were released from their carrier plasmids by BglII digestion and
purified using anion exchange chromatography as described [14].
Introduction of Kan/Neo-loxP-Mu. The initial in vitro
transposition reaction mixture (20 ml) contained 0.185 pmol
(250 ng) transposon DNA (Kan/Neo-loxP-Mu), 500 ng target
BAC DNA digested with an appropriate restriction enzyme,
Figure 8. Comparison of wild type, conditional, and deletion alleles of the mouse Drapc1 locus. (A) A schematic of wild-type (wt),
conditional (cond), and Cre-recombined (del) Drapc1 alleles. (B) Southern blot analysis of DNA isolated from the tails of mice carrying different Drapc1
alleles (AvrII digestion), with the 39probe illustrating the 14.2 kb wild type (wt), 6.4 kb conditional (cond), and 8.3 kb deletion (del) alleles.
doi:10.1371/journal.pone.0004341.g008
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Triton X-100, 10% glycerol (v/v), 120 mM NaCl and 10 mM
MgCl2. Reaction was carried out for 4 h at 30uC. The resulting
transposon-containing fragment pool, purified by phenol and
chloroform extractions and ethanol precipitation, was ligated to
4 mg of the plasmid pHTH22 linearized with the same enzyme as
was used for the initial BAC digestion. The ligation mixture was
purified by phenol and chloroform extractions and ethanol
precipitation, and dissolved in 20 ml of water. Several aliquots
(4 ml) were electroporated into electrocompetent DH10B cells
(50 ml) prepared as described [14] using Genepulser II (Bio-Rad)
and 0.2 cm electrode spacing cuvettes (Bio-Rad) as described [14].
Insert-containing plasmid clones were selected on LB/ampicillin/
kanamycin plates and screened by colony PCR for the presence of
the transposon in the desired DNA region using a pair of
appropriate primers, one transposon-specific and one locus-
specific. The exact location of each identified transposon was
confirmed by initial restriction analysis and subsequent
sequencing.
Removal of Kan/Neo selection marker. The selected
plasmid was electroporated into strain 294-Cre [28] for in vivo
recombination, after which the plasmid was reisolated;
recombination between the two loxP sites was confirmed by
restriction analysis and sequencing. To prevent any potential Cre-
mediated further rearrangements and for the production of good
quality plasmid DNA for further manipulation, the accurately
Cre-recombined plasmid was introduced into E. coli DH10B for
isolation. Note! PCR-based DNA sequencing strategies may not
yield sequencing reads across two Mu ends in inverse relative
orientation, possibly due to intramolecular hybridization
problems. Good quality reads can be obtained by linearizing the
DNA between Mu ends prior to sequencing reactions (e.g. using
EcoRI or XbaI).
Introduction of Kan/Neo-loxP-FRT-Mu. Mu transposition
complexes were initially assembled at 30uCi na2 0ml reaction
volume for 2 h. The assembly mixture contained 4.7 ml (1.1 pmol;
1590 ng) transposon DNA (Kan/Neo-loxP-FRT-Mu), 4 ml5 6
assembly buffer (750 mM Tris-HCl, pH 6.0, 0.125% (w/v) Triton
X-100, 750 mM NaCl and 0.5 mM EDTA), 50% (v/v) glycerol,
and 1 ml (4.9 pmol; 350 ng) MuA. The resulting complexes (1 ml)
were added to the mixture (18 ml), containing 0.55 pmol plasmid
DNA as a target, 25 mM Tris-HCl, pH 8.0, 110 mM NaCl,
0.05% Triton X-100 (w/v), 10% glycerol, and incubated for 5 min
at 30uC to allow target capture. MgCl2 (1 ml) was then added to
the final concentration of 10 mM and incubation was continued
for 2 min in a total volume of 20 ml. The transposition reaction
mixture was electroporated into E. coli DH10B electrocompetent
cells, and transposon-containing clones were selected on LB/
Table 1. Oligonucleotides used in this study.
Oligonucleotide Sequence Usage
HSP478 59-CATCTATGTCGGGTGCGGAGAAAGAG Linker construction, Watson strand
HSP479 59-GTAATGAAATGGCAGCGATCGCGCGGCCG Linker construction, Watson strand
HSP480 59-CCACCGGTGGGCGCGCCGGTACCGTTAACATCGATATG Linker construction, Watson strand
HSP481 59-CATGGATCCGTCGACTCTAGAG Linker construction, Watson strand
HSP482 59-CTCTAGAGTCGACGGATCCATGCATATCGATGTTAAC Linker construction, Crick strand
HSP483 59-GGTACCGGCGCGCCCACCGGTGGCGGCCGCGCGATCG Linker construction, Crick strand
HSP484 59-CTGCCATTTCATTACCTCTTTCTCCGCACCCGACATAGATG Linker construction, Crick strand
HSP485 59-CCGGCCGAATTCATCTATGTCGGGTGCGG Linker amplification, forward
HSP486 59-CCGGCCGAATTCTCTAGAGTCGACGGTACC Linker amplification, reverse
HSP474 59-CTAGGAAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC 1. FRT site construction
HSP475 59-CTAGGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTC 1. FRT site construction
HSP476 59-AAGCTTTTAATTAAGAAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCAT 2. FRT site construction
HSP477 59-GAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCTTAATTAAAAGCTTAT 2. FRT site construction
HSP422 59-CCTCTTCGCTATTACGCCAG Vector-specific sequencing
HSP506 59-AAGCGCATGCTCCAGACTGC Vector-specific sequencing
HSP430 59-ACATTGGGTGGAAACATTCC Tn-specific PCR
HSP432 59-CCCCGGGCGAGTCTAGGGCCGC Tn-specific sequencing
N2 59-GCGTTTTTCGTGCGCCGC Tn-specific PCR
1B59 59-CCGGGCGAGTCTAGGGCCGC Tn-specific PCR
1B39 59-GGGAACACAGAGAGACCCAGAAGC Cdh22 -specific PCR
2B59 59-ATCAACGACAGTGAACCACG Cdh22 -specific PCR
loxP1seq59 59-CACTGGTCGGCCTTCTTCAGG Cdh22-specific sequencing
HSP507 59-CGAGAATCAGAACCTAGCTTGC Drapc1-specific PCR
HSP515 59-GGACTATGGAGACCCTTGC Drapc1-specific sequencing
HSP517 59-ACAGTGGGAAGGAACAATGC Drapc1-specific sequencing
HSP518 59-GAGCATACAAAAGCGGATGG Drapc1-specific PCR
HSP524 59-GGCAGAGCCTTGCAGGGAG Drapc1-specific sequencing
doi:10.1371/journal.pone.0004341.t001
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each candidate clone, the location and orientation of the
transposon were determined by sequencing.
Gene targeting. Targeting constructions were linearized and
electroporated into mouse embryonic stem cells [27]. Desired
clones were cultured using a medium containing G418 (136 mg/
ml) and ganciclovir (2.64 mM) for positive and negative selection,
respectively. The selected ES clones were screened by Southern
blotting with appropriate 59 and 39 probes to verify correct
targeting. Recombinant ES cell clones were used for morula
aggregations to produce chimeras, which transmitted the mutant
alleles through the germ line.
Cre-recombination in mice. The mice carrying the
targeted alleles were crossed with PGK-Cre mice [41]. The
offspring was screened by Southern blotting with appropriate 39
probes using genomic DNA isolated from tails.
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